Jett JE

References (2)

Title : Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia - Walling_2016_Schizophr.Bull_42_335
Author(s) : Walling D , Marder SR , Kane J , Fleischhacker WW , Keefe RS , Hosford DA , Dvergsten C , Segreti AC , Beaver JS , Toler SM , Jett JE , Dunbar GC
Ref : Schizophr Bull , 42 :335 , 2016
Abstract : Walling_2016_Schizophr.Bull_42_335
ESTHER : Walling_2016_Schizophr.Bull_42_335
PubMedSearch : Walling_2016_Schizophr.Bull_42_335
PubMedID: 26071208

Title : Identification and pharmacological characterization of 3,6-diazabicyclo[3.1.1]heptane-3-carboxamides as novel ligands for the alpha4beta2 and alpha6\/alpha3beta2beta3 nicotinic acetylcholine receptors (nAChRs) - Strachan_2014_Eur.J.Med.Chem_86C_60
Author(s) : Strachan JP , Kombo DC , Mazurov A , Heemstra R , Bhatti BS , Akireddy R , Murthy S , Miao L , Jett JE , Speake J , Bencherif M
Ref : Eur Journal of Medicinal Chemistry , 86C :60 , 2014
Abstract : Strachan_2014_Eur.J.Med.Chem_86C_60
ESTHER : Strachan_2014_Eur.J.Med.Chem_86C_60
PubMedSearch : Strachan_2014_Eur.J.Med.Chem_86C_60
PubMedID: 25147147